Legal status of psychedelic drugs in the United Kingdom

This article concerns the legal status of psychedelic drugs in United Kingdom.[1][2][3][4] The legality of psychedelic drugs is regulated in the United Kingdom under bills such as the Misuse of Drugs Act 1971 (including revisions) and the Psychoactive Substances Act 2016.[5][3][6][4][7]

Explicitly controlled substances

Psychedelics, for instance possession and sale, were initially banned under the United Kingdom's Misuse of Drugs Act 1971.[2][8][4] They were made Class A, Schedule 1 controlled substances, the most restrictive classification.[2][8][4] The initially banned psychedelics in 1971 included the tryptamines bufotenin, diethyltryptamine (DET), dimethyltryptamine (DMT), and psilocin; the phenethylamines mescaline and DOM; and the lysergamides ergine (lysergamide; lysergic acid amide; LSA), lysergic acid diethylamide (LSD; lysergide), and other N-alkyl derivatives of ergine.[4] A large number of additional psychedelics subsequently became listed and banned in the Misuse of Drugs Act 1971 through revisions over time.[6][3][4]

Implicitly controlled substances

In addition to explicitly controlled substances, various generic definitions or "catch-most" clauses were added to the Misuse of Drugs Act 1971 starting in 1977 to implicitly blanket-ban drugs from the tryptamine and phenethylamine families.[3][6][9][10][11] There is no blanket-ban clause for lysergamides in the Misuse of Drugs Act 1971 aside from N-alkylated derivatives as of 2022, although various individual lysergamides are banned.[3][4] Many of the psychedelic drugs listed in Alexander Shulgin's books PiHKAL (1991) and TiHKAL (1997) are banned via generic definitions.[3][6][11] The United Kingdom was the first country internationally to adopt generic definition legislation, via the Drugs (Prevention of Misuse) Act 1964.[12]

Before 2016, substances had to be added to the Misuse of Drugs Act 1971 in order to make their supply and use illegal, either via single or generic definitions.[5] This was described as tedious and time-consuming.[5] Moreover, it still allowed legal sale and use of many psychoactive designer drugs, also known as novel psychoactive substances (NPS) or "research chemicals", that evaded such definitions.[5][13] In May 2016, a new law called the Psychoactive Substances Act 2016 was introduced which blanket-banned the production, sale, import, and export of all existing and future psychoactive drugs except certain whitelisted substances like caffeine, alcohol, tobacco or nicotine, food, and prescribed medications.[5][13] The Psychoactive Substances Act 2016 is aimed mainly at suppliers, and unlike the Misuse of Drugs Act 1971, the bill does not criminalize possession or personal use except under special circumstances such as people with intent to supply or in custodial institutions like prison.[5][13][14][7] There was a considerable decline in designer drugs in the United Kingdom, including psychedelics, following the introduction of the Psychoactive Substances Act 2016.[5]

Exceptions

Psilocybin-containing mushrooms were legal in the United Kingdom for many years due to a legal loophole, but both fresh and dried psilocybin-containing mushrooms were banned in 2005.[15][16][17] Psychoactive cacti such as peyote and San Pedro are legal for ornamental purposes and sale in the United Kingdom.[15][18] However, they are illegal if prepared for consumption or actually consumed.[15][18] In contrast to the preceding case, ayahuasca is said to be illegal in the United Kingdom due to containing dimethyltryptamine (DMT).[19]

Psychedelics are legal for scientific research under regulated settings in the United Kingdom.[2][5] Psychedelics that are not controlled under the Misuse of Drugs Act 1971 are exempt from the Psychoactive Substances Act 2016 in the context of basic or clinical research.[5]

Ibogaine was not included in the Misuse of Drugs Act 1971[20] and did not become a controlled substance in the United Kingdom until 2016.[21]

See also

References

  1. ^ Chesak, Jennifer (21 March 2024). "What psychedelics legalisation and decriminalisation looks like around the world". BBC Home. Retrieved 20 January 2026.
  2. ^ a b c d Neill, Joanna (22 April 2024). "It Is High Time the U.K. Changes Psychedelics Laws". The Regulatory Review. Retrieved 8 February 2026.
  3. ^ a b c d e f King, Leslie A (22 July 2022). Forensic Chemistry of Substance Misuse. The Royal Society of Chemistry. doi:10.1039/9781839166631. ISBN 978-1-83916-450-7. Retrieved 9 February 2026.
  4. ^ a b c d e f g "Misuse of Drugs Act 1971". 27 May 1971. Retrieved 8 February 2026.
  5. ^ a b c d e f g h i Hill RG (March 2020). "Understanding the UK Psychoactive Substances Act". Br J Clin Pharmacol. 86 (3): 499–504. doi:10.1111/bcp.14168. PMC 7080622. PMID 31749206.
  6. ^ a b c d King, Leslie A. (2003). The Misuse of Drugs Act: A Guide for Forensic Scientists. Cambridge: Royal Society of Chemistry. doi:10.1039/9781847552112. ISBN 978-0-85404-625-6. Retrieved 9 February 2026.
  7. ^ a b "Psychoactive Substances Act 2016". Retrieved 9 February 2026.
  8. ^ a b Nutt D (March 2020). "New psychoactive substances: Pharmacology influencing UK practice, policy and the law". Br J Clin Pharmacol. 86 (3): 445–451. doi:10.1111/bcp.14209. PMC 7080626. PMID 31917863.
  9. ^ King LA (2014). "New phenethylamines in Europe". Drug Test Anal. 6 (7–8): 808–818. doi:10.1002/dta.1570. PMID 24574327. In the United Kingdom Misuse of Drugs Act, most ring-substituted phenethylamines are either listed by name or are covered by generic definitions dating from 1977. In 2013, temporary generic legislation included a number of benzofurans, indanylalkylamines and certain 'NBOMe' compounds. [...] Table 1 excludes those phenethylamines and related compounds (e.g. N-benzylamphetamine, N-ethylamphetamine) listed in Schedule IV of the 1971 Convention; few were commonly misused and are all now regarded as obsolete pharmaceutical products. In the UK, a 1977 generic modification[6] to the Misuse of Drugs Act (Table 2) captured a wide range of ring-substituted phenethylamines; a further 35 compounds, none of which was subsumed by that generic definition, were added by name in 2001.[7,8] In 2013, temporary generic legislation included a number of benzofurans, indanylalkylamines and certain NBOMe compounds.[9]
  10. ^ "The Misuse of Drugs Regulations 2001". Retrieved 9 February 2026.
  11. ^ a b McCandless, David (26 May 2005). "Dawn raids mark crash of online designer drugs trade". The Guardian. Retrieved 9 February 2026. The UK has the strictest laws in the EU on designer drugs. The Misuse Of Drugs Act was amended in 2002 to include a "catch most" clause outlawing every drug, and possible future drug, from the LSD (tryptamine) and ecstasy (phenethylamine) chemical families. The amendment is a virtual cut-and-paste from the books of the respected American biochemist Alexander Shulgin, who obtained a PhD from the University of California, Berkeley. Dr Shulgin, a former research chemist at the Dow Chemical Company, re-discovered the recipe for MDMA in 1976 and published the recipes for more than 170 designer drugs of his own invention.
  12. ^ King, Leslie A. (2013). "Legal Classification of Novel Psychoactive Substances". Novel Psychoactive Substances. Elsevier. p. 3–27. doi:10.1016/b978-0-12-415816-0.00001-8. ISBN 978-0-12-415816-0. Retrieved 9 February 2026. The UK was the first country to introduce generic controls. [...] In 1964 [29], an attempt was made to group a large number of CNS stimulants into a single definition. The Drugs (Prevention of Misuse) Act contained the definition (with certain named exceptions): Any synthetic compound structurally derived from either α-methylphenethylamine or β-methylphenethylamine by substitution in the side chain, or by ring closure therein, or by both such substitution and such closure… [...] This generic control was repealed in 1970. Following this early failure, it would be some years before generic control of phenethylamines again entered the legislation. But this time (1977), the focus was on ring-substituted phenethylamines; this was, more robust and was be followed by generic controls for many other groups. Table 1.1 lists the groups for which generic control now exists in the UK under the Misuse of Drugs Act, 1971, showing their year of introduction and classification.
  13. ^ a b c Turk, Victoria (26 May 2016), The UK Has Banned Drugs That Don't Even Exist Yet, retrieved 9 February 2026, The Psychoactive Substances Act came into effect on Thursday and is essentially a blanket ban on the production, supply, import and export of any substance that has an effect on the brain. (It does not cover possession, unless it's with the intent to supply, or you're in a prison or a young offender institution.)
  14. ^ van Amsterdam J, Burgess N, van den Brink W (2023). "Legal Approaches to New Psychoactive Substances: First Empirical Findings". Eur Addict Res. 29 (5): 363–372. doi:10.1159/000531503. PMID 37557091. Simple possession of NPS for personal use outside custodial settings is not a criminal offence under the [U.K. Psychoactive Substances Act 2016 (PSA)], [...]
  15. ^ a b c "Worldwide Psychedelic Laws". Psychedelic Alpha. 15 December 2021. Retrieved 8 February 2026. It's legal to grow psychoactive cacti for ornamental purposes in the U.K., but is illegal to use them. Cacti containing mescaline can be legally grown for ornamentation purposes in the U.K. They are illegal, however, if dried, cut into 'buttons', or prepared otherwise for consumption purposes. Mescaline is classified as a Class A drug. Due to a legal loophole, fresh psychedelic mushrooms were legal in the UK until 2005, but this loophole was closed making fresh and dried magic mushrooms illegal. Former Prime Minister Boris Johnson was considering rescheduling psilocybin mushrooms, with no further discussion from his administration.
  16. ^ Honigsbaum, Mark (29 November 2003). "High times in magic mushroom business". the Guardian. Retrieved 13 February 2025.
  17. ^ Oliver, Mark (18 July 2005). "Law spells end for mushrooming trade". the Guardian. Retrieved 13 February 2025.
  18. ^ a b Mowling, Rebecca (13 April 2012). "Drug legally sold on street". The Standard. Retrieved 9 February 2026.
  19. ^ Thelwell, Emma (29 April 2014). "Why do people take ayahuasca?". BBC News. Retrieved 9 February 2026. Ayahuasca, also known as yage, is a blend of two plants - the ayahuasca vine (Banisteriopsis caapi) and a shrub called chacruna (Psychotria viridis), which contains the hallucinogenic drug dimethyltryptamine (DMT). DMT - and therefore ayahuasca - is illegal in the UK, the US and many other countries.
  20. ^ Corkery JM (2018). "Ibogaine as a treatment for substance misuse: Potential benefits and practical dangers". Prog Brain Res. 242: 217–257. doi:10.1016/bs.pbr.2018.08.005. PMID 30471681.
  21. ^ Hannaford, Alex (10 December 2017). "Dying to get clean: is ibogaine the answer to heroin addiction?". The Guardian. Retrieved 8 February 2026.
This article is issued from Wikipedia. The text is available under Creative Commons Attribution-Share Alike 4.0 unless otherwise noted. Additional terms may apply for the media files.